Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · IEX Real-Time Price · USD

2.310

+0.030 (1.32%)

At close: Jul 2, 2024, 1:02 PM

2.325

+0.015 (0.65%)

After-hours: Jul 2, 2024, 4:00 PM EDT

Cyclerion Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	-5.26	-44.08	-51.65	-77.8	-123.01	Upgrade
Depreciation & Amortization	0	0.07	0.47	2.3	2.7	Upgrade
Share-Based Compensation	1.07	6.25	9.61	14.99	19.63	Upgrade
Other Operating Activities	-17.05	-2.85	5.05	-11.98	-1.54	Upgrade
Operating Cash Flow	-21.25	-40.61	-36.52	-72.49	-102.22	Upgrade
Capital Expenditures	0	0	1.46	0.02	-6.72	Upgrade
Acquisitions	10.4	0	0	0	0	Upgrade
Investing Cash Flow	10.4	0	1.46	0.02	-6.72	Upgrade
Share Issuance / Repurchase	5.02	0.03	30.79	24.58	175.51	Upgrade
Debt Issued / Paid	0	0	0	3.51	0	Upgrade
Other Financing Activities	-	-	-	-	36.06	Upgrade
Financing Cash Flow	5.02	0.03	30.79	28.09	211.57	Upgrade
Exchange Rate Effect	0.01	0	0	-0.01	-0.02	Upgrade
Net Cash Flow	-5.81	-40.58	-4.27	-44.39	102.62	Upgrade
Free Cash Flow	-21.25	-40.61	-35.06	-72.47	-108.93	Upgrade
Free Cash Flow Margin	-	-13673.74%	-889.40%	-3156.45%	-2416.91%	Upgrade
Free Cash Flow Per Share	-9.09	-18.69	-16.19	-42.68	-79.31	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).